...
首页> 外文期刊>Clinical and experimental ophthalmology >Phaco-microtrabeculectomy: technique and intraocular pressure control in comparison with microtrabeculectomy.
【24h】

Phaco-microtrabeculectomy: technique and intraocular pressure control in comparison with microtrabeculectomy.

机译:晶状体微小梁切除术:与微小梁切除术相比,技术和眼压控制。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To describe a modified technique for combined cataract and glaucoma drainage surgery involving a small flap (micro) trabeculectomy combined with phaco-emulsification (PMT). To assess the level of intraocular pressure (IOP) control achieved by this procedure in comparison with microtrabeculectomy (MT) alone. METHODS: In this retrospective controlled case series records were reviewed for 37 consecutive low-risk patients undergoing PMT augmented with 5-fluorouracil (5-FU) and 37 low-risk subjects undergoing MT with 5-FU. IOP control was compared by survival analysis using IOP targets or = 21 mmHg and or = 16 mmHg at final follow up and with at least a 25% reduction from the preoperative pressure. RESULTS: Mean follow up was 41.7 months (range 19.0-72.0) in the PMT group and 43.5 months (range 18.0-66.0) in the MT group. A final IOP or = 21 mmHg and with at least a 25% reduction from the preoperative pressure was achieved in 91.9% patients undergoing PMT (70.3% on no glaucoma drops). IOP or = 16 mmHg and with at least a 25% reduction from the preoperative pressure was achieved in 67.6% (56.8% without drops). There were no significant differences in survival rates between PMT and MT for either IOP target. The mean final IOPs were 13.4 and 13.5 mmHg on a mean of 0.6 and 0.8 glaucoma drops in the PMT and MT groups, respectively. In the PMT final visual acuity improved by at least one Snellen line in 81.1% and was worse in a single eye. CONCLUSIONS: IOP control following combined surgery by PMT is as good as following MT alone.
机译:目的:描述一种改良的技术,用于白内障和青光眼联合引流手术,包括小瓣(微)小梁切除术和超声乳化术(PMT)。与单独的小梁切除术(MT)相比,评估通过此程序实现的眼内压(IOP)控制水平。方法:在此回顾性对照病例系列研究中,回顾了37例接受5-氟尿嘧啶(5-FU)增强的PMT的低危患者和37例接受5-FU的MT的低危患者。通过IOP靶标<或= 21 mmHg和<或= 16 mmHg,并在最终随访时与术前压力相比降低至少25%,通过生存分析比较了IOP控制。结果:PMT组平均随访41.7个月(范围19.0-72.0),MT组平均随访43.5个月(范围18.0-66.0)。在接受PMT的91.9%的患者中,最终IOP <或= 21 mmHg,并且比术前压力降低了至少25%(无青光眼滴注的患者为70.3%)。 IOP <或= 16 mmHg,与术前压力相比降低至少25%,达到67.6%(56.8%,无滴落)。对于任一IOP目标,PMT和MT的生存率均无显着差异。 PMT组和MT组的平均最终IOP分别为13.4和13.5 mmHg,平均青光眼滴分别为0.6和0.8。在PMT中,最终视力至少提高了一条Snellen线,达到81.1%,单只眼睛的视力更差。结论:PMT联合手术后的眼压控制与单纯MT一样好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号